Serum Institute of India | The Business Standard

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

Coronavirus chronicle

UK to receive 10 million AstraZeneca Covid-19 vaccine doses from India's Serum Institute

The UK has ordered 100 million doses of AstraZeneca’s Covid-19 vaccine, of which 10 million doses will come from the Serum Institute of India

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier

Coronavirus chronicle

India sends first vaccine doses to Africa under WHO's Covax programme

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

Coronavirus chronicle

Serum Institute says prioritising domestic vaccine needs, asks for patience

A healthcare worker fills a syringe with a dose of Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) at a vaccination centre opened at the Yandex Go centre for drivers and couriers in Moscow, Russia January 27, 2021. REUTERS/Maxim Shemetov

Coronavirus chronicle

Nepal approves Chinese Covid-19 vaccine, to make first purchases from India

FILE PHOTO: Workers from Afghan health ministry unload boxes containing vials of COVISHIELD, a coronavirus disease (Covid-19) vaccine donated by Indian government in Kabul, Afghanistan February 7, 2021. REUTERS/Omar Sobhani/File Photo

Coronavirus chronicle

India to gift 2,00,000 doses of coronavirus vaccine to UN peacekeepers

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

Coronavirus chronicle

South Africa asks Serum Institute of India to take back one million vaccine doses - Report

An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India Photo: Reuters/Francis Mascarenhas

Coronavirus chronicle

India's Serum says will ship AstraZeneca vaccine to Canada in 'less than a month'

Covid-19 vaccine. Photo/Courtesy

Coronavirus chronicle

First doses of Covid-19 vaccine arrive in Afghanistan from India

A health department employee counts vials of the vaccine developed by Oxford/AstraZeneca as she prepares to pack them up before they are transported from the state storage to a regional one, during the coronavirus disease (Covid-19) pandemic, in Bhubaneswar, India, January 13, 2021. REUTERS/Danish Siddiqui

Coronavirus chronicle

Serum India’s Covishield part of Pakistan’s Covid-jab drive under vaccine alliance

A health department employee counts vials of the vaccine developed by Oxford/AstraZeneca as she prepares to pack them up before they are transported from the state storage to a regional one, during the coronavirus disease (Covid-19) pandemic, in Bhubaneswar, India, January 13, 2021. REUTERS/Danish Siddiqui

Coronavirus chronicle

Mexico to import AstraZeneca vaccine from India, president says

A medical worker receives the AstraZeneca's Covishield coronavirus disease (Covid-19) vaccine in Yangon, Myanmar, after the country received 1.5 million doses of the vaccine manufactured by the Serum Institute of India, January 27, 2021. REUTERS/Shwe Paw Mya Tin

Coronavirus chronicle

Myanmar launches vaccination drive, prioritises frontline healthcare workers

Coronavirus chronicle

Saudi Arabia to get AstraZeneca shots in about a week from India

Reena Jani, 34, a health worker, receives the vaccine developed by Oxford/AstraZeneca at Mathalput Community Health Centre, during the coronavirus disease (Covid-19) pandemic, in Koraput, India, January 16, 2021. REUTERS/Danish Siddiqui

Coronavirus chronicle

From factory to faraway village: Behind India's mammoth vaccination drive